tPA
Line Care:
CathFlo for declotting central venous catheter: See Policy 904.4009
Stroke Protocol/Guidelines - NOTE: tenecteplase is the formulary thrombolytic for treatment of ischemic stroke at Legacy, where indicated
Eligibility for IV Treatment with a Thrombolytic for Stroke: See Policy 900.5007
Nursing management of stroke in ED: See Policy 905.5002
Code Stroke for Adult Admitted Patients: See Policy 900.6522
Other Protocol/Guidelines:
Thrombolytic therapy for massive/submassive pulmonary embolism (PE): See Policy 900.5003
Use of t-PA and Dornase alpha in pleural infections (Intrapleural administration): See Policy 900.3028
Alteplase for therapeutic indications may only be ordered via Order Set (including stroke, PE, DVT, pulmonary instillation). See 900.3233 Medications: Orders
Reversal/Discontinuation:
Neuraxial Anesthesia and Anticoagulation: see Guideline 900.5681
Reversal of tPA: See Reversal Guideline 900.5010
Line Care:
CathFlo for declotting central venous catheter: See Policy 904.4009
Stroke Protocol/Guidelines - NOTE: tenecteplase is the formulary thrombolytic for treatment of ischemic stroke at Legacy, where indicated
Eligibility for IV Treatment with a Thrombolytic for Stroke: See Policy 900.5007
Nursing management of stroke in ED: See Policy 905.5002
Code Stroke for Adult Admitted Patients: See Policy 900.6522
Other Protocol/Guidelines:
Thrombolytic therapy for massive/submassive pulmonary embolism (PE): See Policy 900.5003
Use of t-PA and Dornase alpha in pleural infections (Intrapleural administration): See Policy 900.3028
Alteplase for therapeutic indications may only be ordered via Order Set (including stroke, PE, DVT, pulmonary instillation). See 900.3233 Medications: Orders
Reversal/Discontinuation:
Neuraxial Anesthesia and Anticoagulation: see Guideline 900.5681
Reversal of tPA: See Reversal Guideline 900.5010